阿托伐他汀联合丹红注射液对颈椎病致脑供血不足患者的治疗作用探讨.docVIP

阿托伐他汀联合丹红注射液对颈椎病致脑供血不足患者的治疗作用探讨 　　【摘要】 目的 探?阿托伐他汀联合丹红注射液对颈椎病致脑供血不足患者的治疗作用。方法 150例颈椎病致脑供血不足患者， 随机分为对照组和观察组， 各75例。对照组患者接受常规治疗， 观察组患者在常规治的基础上接受阿托伐他汀联合丹红注射液治疗。观察两组临床疗效。结果 对照组患者临床总有效率为46.7%， 观察组患者为66.7%， 观察组患者临床疗效高于对照组（P0.05）。治疗前， 观察组患者左侧椎动脉最大流速为（33.8±1.4）cm/s， 右侧椎动脉最大流速为（32.1±1.6）cm/s， 治疗后， 观察组患者分别为（46.5±1.5）、（45.8±13.3）cm/s；治疗前， 对照组患者左侧椎动脉最大流速为（33.2±1.0）cm/s， 右侧椎动脉最大流速为（34.2±1.3）cm/s， 治疗后， 对照组患者分别为（40.0±1.2）、（40.5±1.5）cm/s；治疗后两组患者两侧椎动脉最大流速均得到改善， 且观察组患者改善情况优于对照组， 差异具有统计学意义（P0.05）。结论 阿托伐他汀联合丹红注射液治疗颈椎病致脑供血不足可明显改善患者两侧椎动脉最大流速， 值得临床推广。 　　【关键词】 阿托伐他汀；丹红注射液；颈椎病；脑供血不足 　　DOI：10.14163/j.cnki.11-5547/r.2017.04.013 　　【Abstract】 Objective To investigate curative effect by atorvastatin combined with Danhong injection in the treatment of cervical spondylosis-induced insufficient cerebral blood supply. Methods A total of 150 patients with cervical spondylosis-induced insufficient cerebral blood supply were randomly divided into control group and observation group， with 75 cases in each group. The control group received conventional therapy， and the observation group received additional atorvastatin combined with Danhong injection on conventional therapy for treatment. Clinical effects were observed in both groups. Results The observation group had total clinical effective rate as 46.7%， which was 66.7% in the observation group. The observation group had higher clinical effect than the control group （P0.05）. Before treatment， the observation group had left vertebral artery maximum flow velocity as （33.8±1.4） cm/s and right vertebral artery maximum flow velocity as （32.1±1.6）cm/s. After treatment， those were respectively （46.5±1.5） and （45.8±13.3） cm/s in the observation group. Before treatment， the control group had left vertebral artery maximum flow velocity as （33.2±1.0） cm/s and right vertebral artery maximum flow velocity as （34.2±1.3） cm/s. After treatment， those were respectively （40.0±1.2） and （40.5±1.5） cm/s in the control group. Both groups had improved bilateralvertebral